Ever-busy Colisee is set to rent five Spanish care homes from Adriano Care Socimi. HBI speaks with Carlos Araoz, a partner at Adriano, to find out more about the market.
Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.
Big private equity players in health care face a choice as to whether to go for Pan-European imaging group Affidea which is for sale through Goldman Sachs or for IVI RMA, the international fertility group.
Cerba Healthcare, France’s largest laboratory group by revenue, has acquired Yourlab, a medium-sized clinical pathology company based in the west of France.
Orpea's smaller PE-backed French rivals who are spilling out across Europe say they are not worried by the Orpea scandal. Colissee has just acquired in Portugal for the first time. HBI talks to the C-level at the French operator to learn more.
After a strong performance in 2021, international lab group Eurofins plans to build diagnostic lab hubs, which will enable it to increase the volume of tested samples. HBI talks with the source close to the company to find out more.
Multiple sources have told HBI that fast-growing German and Swiss ophthalmology group Sanoptis might be looking at a Q2 sale, but HBI understands that is not entirely correct. HBI speaks to Sanoptis CEO Volker Wendel to set the record straight.
A major French operator, the Doctegestio group, has launched a new platform called Avec which combines everything from dentistry and primary care to hospital and nursing homes. We talk to Bernard Bensaid, the entrepreneur behind Avec.
HBI hears Lusiadas Saude, Portugal’s third-largest hospital group by revenue, is for sale. Meanwhile, imaging and labs may be affected by the surprise re-election of the leftist Socialist government. HBI speaks with a healthcare consultant in Portugal to find out more.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
